Coenzyme Q10 Supplementation for the Treatment of statin-associated Muscle Symptoms is a research paper published in Future Cardiology (2022). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: K08 HL146990, L30 HL110279, R01 HL085800, R21 AR055704
NHLBI NIH HHS
Grant: K08 HL146990
NHLBI NIH HHS
Grant: L30 HL110279
NIAMS NIH HHS
Grant: R21 AR055704
NHLBI NIH HHS
Grant: R01 HL085800
National Institutes of Health
Grant: 5R01HL085800-04
GENETIC SUSCEPTIBILITY TO LIPID-LOWERING DRUG-INDUCED MYOPATHIES
National Institutes of Health
Grant: 5K08HL146990-03
Precision Medicine for Heart Failure: The Role of Genomics in the Efficacy and Racial Disparity of Cornerstone Pharmacotherapy
National Institutes of Health
Grant: 1R21AR055704-01
Role of Narexin in Neuromuscular Disease
John R. Oishei Foundation
University at Buffalo Office of the Vice President for Research
Influential Citations
1
Fields of Study
MeSH Terms
Keywords
Supplementary material: Coenzyme Q10 supplementation for the treatment of statin-associated muscle symptoms
Supplementary material: Coenzyme Q10 supplementation for the treatment of statin-associated muscle symptoms